“Global
Retinoblastoma Treatment Market 2015-2019” is the latest
addition to MarketResearchReports.Biz industry research reports
collection.
About retinoblastoma
Cancer occurs when normal
cells transform to evade the regular cell cycle process.
Retinoblastoma is a rare eye cancer. It occurs in children of age
less than 15 years; the disease is common in children younger than
five years, especially children less than two years. The disease
affects the retina and is caused by a mutation in the gene RB1. It
usually appears in one eye and gradually spreads to the other.
Clinically, retinoblastoma is classified into two: unilateral
retinoblastoma, tumor in one eye, and bilateral retinoblastoma, tumor
in both the eyes.
Technavio's analysts forecast
the global retinoblastoma market to grow at a CAGR of 3.57% over the
period 2014-2019.
Download Sample copy of
this Report @
Covered in this report
The report includes the
present scenario and the growth prospects of the global
retinoblastoma market for the period 2015-2019. To calculate the
market size, the report considers revenue generated from the sales of
various drugs used in the treatment of retinoblastoma.
Technavio's report, Global
Retinoblastoma Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from industry experts. It covers
the market size and forecast as well as the market segmentation. The
report includes a discussion of the key vendors operating in this
market.
Key regions
- Americas
- APAC
- EMEA
Key vendors
- Baxter
- Bristol-Myers Squibb
- GlaxoSmithKline
- Spectrum Pharmaceuticals
Other prominent vendors
- BioLineRx
- Cellceutix
- Icon Bioscience
- Neotropix
- RXi Pharmaceuticals
Key market driver
- Increasing public awareness
- For a full, detailed list, view our report
Key market challenge
- Treatment abandonment
- For a full, detailed list, view our report
Key market trend
- Localized treatment approach
- For a full, detailed list, view our report
For
Market Research Latest Reports Visit @ Global
Portable Ultrasound Market 2015-2019
About portable
ultrasoundPortable ultrasound devices are medical imaging devices
that utilize echo-enhanced ultrasound waves for diagnostic purposes.
Portable ultrasound devices
can be used at POC and can be operated on battery power. They are
lighter and smaller than conventional ultrasound
machines.Conventional ultrasound machines have certain limitations
such as low diagnostic accuracy and difficulty in imaging patients
who are overweight as sound waves in these machines did not pass
deeper into the body.
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
About us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact us:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
No comments:
Post a Comment